Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder
Clinical trial NCT05053503 · COMPLETED
Trial details
- NCT number
- NCT05053503
- Sponsor
- Spark Biomedical, Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-27
- Primary completion
- 2025-04-04
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.